Mutational Analysis of BRCA1/2 in Ovarian Cancer Patients

13 August 2019

At the European Society of Human Genetics (ESHG) conference 2019, Dr. Bartosz Wasag, Medical University of Gdansk & University Clinical Centre, Gdansk, Poland, presents a cost-effective, highly-sensitive approach for the analysis of variants in breast and ovarian cancer-associated BRCA1 and BRCA2 genes. Using amplicon-based next-generation sequencing (NGS) technology from Agilent Technologies, this approach may be applicable for routine diagnostics in the future.